The Valley Desk

Clinical trial reportScience (New York, N.Y.)Published

Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Science (New York, N.Y.)
Published
Subject terms
CD8-Positive T-Lymphocytes; Animals; Humans; Mice; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Immunotherapy; Female; Janus Kinase 1; Programmed Cell Death 1 Receptor; Janus Kinase Inhibitors; Immune Checkpoint Inhibitors
PubMed ID
38900877
PubMed Central ID
PMC11327955
Added to directory
Source checked

Report a correction or request removal